Exclusive breastfeeding (EBF) during the first six months of Background: life is critical for child's linear growth. While there is strong evidence in favor of EBF, the evidence with regards to other interventions for linear growth is unclear. We evaluated intervention domains of micronutrients, food supplements, deworming, maternal education, water sanitation and hygiene (WASH), and kangaroo care, for their comparative effectiveness on linear growth.
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Introduction
In past decades, important progress achieved in maternal, newborn, and child health (MNCH) have led to substantial reductions in maternal and child mortality rates 1, 2 . However, many children still fail to reach their linear growth potential, particularly those living in low-and middle-income countries (LMICs) 3 . Linear growth in early childhood is a marker of healthy development that is closely linked with neurodevelopment 4 . The first six months of age (birth to 6 months), known as the exclusive breastfeeding period, is a critical life stage for early child development. There is a strong evidence to support the benefits of exclusive breastfeeding during this life stage [5] [6] [7] . As such, mechanisms and resources to facilitate appropriate self-care in addition to psycho-social support for breastfeeding mothers is necessary to improve both health outcomes of mothers and babies. For instance, poor maternal nutrition could lead to lactation issues creating barriers for mothers to exclusively breastfeed 3 . Inadequate care, poor hygiene, and control of diseases for infants and mothers may also inadvertently limit the growth of infants who are adequately breastfed 3, 8, 9 .
The current evidence for other interventions, such as micronutrients, food supplements, deworming, maternal education, and kangaroo care (i.e. early skin-to-skin care) interventions is unclear for the exclusive breastfeeding life stage. Although there are numerous published reviews aimed to assess the effectiveness of these interventions that can be provided during exclusive breastfeeding period (Table 1) , their scope has been limited to summarize the comparative effectiveness of a single intervention or interventions within a single domain only. Given that determinants of linear growth for exclusive breastfeeding period is multi-faceted, there is a need to summarize the evidence base of interventions from multiple intervention domains, since multi-domain intervention solutions are likely needed to tackle this problem.
This article uses a comprehensive literature review for multiple intervention domains of micronutrient, food supplements, deworming, maternal education, water sanitation and hygiene (WASH), and kangaroo care to summarize their effects on linear growth for LMIC-based infants in the exclusive breastfeeding period. For our quantitative summary, we have used network meta-analysis for all interventions except for kangaroo care to summarize their effects on LAZ and stunting outcomes; kangaroo care was assessed using pairwise metaanalysis. As the data was too sparse to facilitate meta-analysis, we qualitatively summarized the evidence base for outcomes length and head circumference.
Methods
Our analysis and report was designed and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) extension to network meta-analysis 23 .
The protocol for this study was registered in PROSPERO (CRD42018110450).
Search strategy and selection criteria
Our search strategy was developed after first reviewing the papers published in the Lancet 2013 Maternal and Child Nutrition series 3,24 , inclusive of the umbrella review by Bhutta and colleagues 7 , for an overview of the literature. Specifically, we hand-searched the bibliography of Bhutta et al. 7 for relevant systematic reviews, global health guidelines, and LMIC-based trials. We also performed additional searches in PubMed and the Cochrane Database of Systematic Reviews for more recent trials and other reviews published after 2013. The list of published reviews relevant to this study is provided in Table 1 .
For our systematic literature search, we scanned the following databases from inception to August 28, 2019: the Cochrane Central Register of Controlled Trials, Embase, and MEDLINE (Extended data, Supplementary Tables 1-3) 25 . To increase the sensitivity of our search, we complemented our database searches with relevant trials identified from bibliographies of prior reviews. A team of four reviewers (JJHP, ES, LD, and RM) independently reviewed all abstracts and proceedings identified in the literature searches. The same team independently conducted relevant full-text reviews of relevant papers. If any discrepancies occurred between the studies selected by the same reviewers, a third investigator (KT) provided arbitration.
Using a standardized data sheet in Microsoft Excel, four investigators (JJHP, VJ, NEZ, and HG) independently extracted data for study characteristics, interventions used, patient characteristics at baseline, and outcomes from the final list of selected eligible studies. Any discrepancies observed during data extraction were resolved through discussion between the investigators until consensus was reached.
Evidence synthesis and data analysis When sufficient data was available for quantitative assessment, a network meta-analysis or pairwise meta-analysis approach was applied. For all domains of interventions except for kangaroo care, we performed a network meta-analysis for LAZ and stunting. There was a limited number of studies that reported on length and head circumference, so we qualitatively synthesized findings from these trials as an alternative to quantitative analysis. We did not consider kangaroo care as part of the network meta-analysis since these trials involved a shorter intervention duration and follow-up (median follow-up of 2 weeks).
We performed a network meta-analysis within the Bayesian framework in R using the R2WinBUGS v14 package 26, 27 . Bayesian models were performed according to the National Institute for Health and Care Excellence (NICE) in their Technical Support Document 2 (TSD2) 28 . Estimates of comparative effectiveness were measured using mean differences in LAZ with the associated 95% credible intervals (95% CrI). In all models, we used an empirically informative heterogeneity prior distribution, as suggested by Rhodes et al. 2016 29 for LAZ and Turner et al. 2015 30 for stunting. This was done to stabilize the estimation of heterogeneity in the face of low number of trials per comparison in the network. Our model selection was informed by using the deviance information criterion and the deviance-leverage plots that could help identify outlier(s) in terms of model fit, in accordance with the NICE TSD2 recommendations 28 .
For our primary network meta-analysis, we included both cluster and non-cluster randomized clinical trials (with the unit of randomization set at the individual level). To adjust for clustering effects of the cluster trials, we assumed a conservative intra-cluster correlation coefficient (ICC) of 0.05, and we inflated variances accordingly for continuous outcomes and adjusted the sample sizes and the number of cases for dichotomous outcomes, as recommended by Uhlmann et al. 31 We performed a sensitivity analysis by excluding cluster randomized clinical trials in our network meta-analysis. For our pairwise meta-analysis on kangaroo care, we performed a random-effects model using the Metafor R package (in R2WinBUGS v14) 32 . For our network meta-analysis, the estimates of effectiveness were measured using mean differences or relative risk with accompanying 95% credible intervals (CrIs). The estimates of effectiveness were measured using mean differences with accompanying 95% confidence intervals (CIs) for our pairwise meta-analysis on kangaroo care. As no kangaroo care trials involved cluster randomization, our pairwise meta-analysis did not need to adjust for the clustering effect.
Risk of bias within and across studies
Each full text article was evaluated for reporting quality according to the Cochrane Risk of Bias Tool 33 . The risk of bias assessment within and across studies are provided in the Extended data ( Supplementary Table 8 ) 25 .
Results
We identified 20,224 abstracts from our database searches and hand searching of reference lists from published reviews ( Figure 1 ). Of these, 1099 studies underwent a full-text review, and 40 papers reporting on 29 trials met our inclusion criteria. In total, these trials pertained to 35,119 participants that were randomized to 73 unique interventions (Figure 2 ). The list of the final subset is provided in Table 2 , and the list of excluded studies (Extended data, Supplementary Table 5 ) 25 is provided in the online appendix.
The trial characteristics of the included studies (Extended data, Supplementary Table 6 ) 25 are provided in the online appendix. Of the 29 included trials, ten were cluster randomized trials (1156 clusters; 24,389 mother-infant dyads). The majority of trials were conducted in Southeastern Asian (n = 14) and African (n = 10) countries, and involved individual randomization (i.e. non-cluster trials, n = 19) and were open-label trials (n = 9). Several trials (n = 24) focused on a single domain of interventions, with micronutrient (n = 11) and food supplements (n = 9) being the most common intervention domains investigated. There were four trials that investigated interventions from two different intervention domains 34-37 , but the scope of these trials was still limited to nutritional (micronutrient and food) supplementations. There was one trial reporting on deworming study 38 and another on WASH intervention 39 , and there were five trials on kangaroo care. There were 24 trials that investigated other intervention domains (non-kangaroo care trials), the median duration of interventions was 24 weeks (IQR: 12, 24 weeks). The kangaroo care trials entailed short follow-ups, with intervention durations that varied between one to two weeks.
The patient baseline characteristics are provided in the online appendix (Extended data, Supplementary Table 7 ) 25 . The median age of mothers at enrollment was 25.4 years (ranging from 21.8 to 29.8 years). For infants, the majority of trials enrolled participants from birth (after follow-up of the mother) or within the first month of life, except one trial 40 that investigated the effects of food supplements for an early weaning off breastfeeding enrolled patients at 4 months of age (up to 7 months of age). The proportion of boys included in these trials was 51.3% on average, ranging from 36.6% 39 to 73% 41 . Network meta-analysis on LAZ The LAZ network (Extended data, Supplementary Figure 1 ) 25 included 18 trials consisting of 27,896 mother-infant dyads randomized to 52 intervention arms. The results of our primary analysis on LAZ that included both cluster and non-cluster randomized clinical trials are illustrated in Figure 3 . Network meta-analysis on stunting The stunting network (Extended data, Supplementary Figure 3 ) 25 included 18 trials that consisted of 27,896 mother-infant dyads randomized to 52 intervention arms. The results of our primary analysis that included both cluster and non-cluster randomized clinical trials are illustrated in Extended data, Supplementary Figure 9 25 . While supplementations of zinc 
Sensitivity analyses on LAZ and stunting
Our sensitivity analyses were limited to individually (noncluster) randomized clinical trials only. The network diagrams for LAZ (Extended data, Supplementary Figure 2 ) 25 and stunting (Extended data, Supplementary Figure 4 ) 25 can be found online along with forest plots (Extended data, Supplementary  Figures 10 and 11) 25 and cross-tables (Extended data, Supplementary Table 9 and 10) 25 . In our sensitivity analysis on LAZ, no interventions showed improvements for LAZ when compared to standard-of-care, and similarly for stunting, no interventions showed reduced risks for stunting. This is likely due to very few studies being available for sensitivity analyses; only nine trials were available for LAZ and stunting analyses.
Kangaroo care
Five randomized clinical trials investigating the effects of kangaroo care on linear growth of newborns were included in the pairwise meta-analysis 41, 45, 48, 55, 69 . The outcome reporting of these kangaroo care trials was limited to growth velocity of head circumference and length (cm per week). All kangaroo care trials were conducted in Southeastern Asian countries (i.e. India, Malaysia, and Nepal), in hospital settings and involved low birthweight neonates. Kangaroo care consisted of skin-to-skin contact between the mothers' breasts, where infants in the control group were kept under either a warmer or incubator. The effects of kangaroo care on head circumference and length growth velocities are shown in Extended data, Supplementary  Figures 12 and 13 25 , respectively. All studies except for Acharya 2014 41 showed improvements in head circumference (Mean (SD): 31.5 (1.4) 95%CI -0.5, 0.6 45 ; Kangaroo mother care (KMC): 0.75 cm vs conventional method of care (CMC): 0.49 cm p<0.001 55 ;) and length (KMC: 0.99 cm vs CMC 0.70 cm p<0.001 55 ). The pooled estimates of growth velocities for head circumference and length showed improvements for kangaroo care in comparison to the control. Relative to the control, kangaroo care showed an improved mean difference of 0.20 cm/week (95% CI: 0.09, 0.31 cm/week) for head circumference, and for length, a mean difference of 0.23 cm/week (95% CI: 0.10, 0.35 cm/week).
Qualitative summary of trials reporting on length and head circumference
There were twelve trials available for our qualitative summary 37, 38, 40, 47, 51, 53, 56, 60, [63] [64] [65] 71 . Of these trials, three were cluster randomized clinical trials that investigated interventions related to maternal education and breastfeeding promotion: Le Roux 56 Vazir 71 , and PROMISE EBF 65 did not find differences in their maternal education and breastfeeding promotion interventions. In this three-arm trial conducted in India, mothers in the Complementary Feeding group (n = 202; 20 clusters) received nutrition education messages on breastfeeding and complementary feeding from CHWs, and the mothers in the Complementary Feeding + Play group (n = 195; 20 clusters) received messages on psychosocial stimulation in addition to the same nutritional messages received by the women in the complementary Additionally, nine trials investigated the effect of nutritional interventions (four trials on micronutrient supplements, three on food supplements, one on both, and one other for deworming) on the incidence of changes in head circumference, or changes in length 37, 38, 40, 47, 53, 60, 63, 64, 71 . Of these nine trials, JiVitA-3 trial 53, 54, 73 and Ostadrahimi 64 provided supplements to mothers from pregnancy into postpartum, where the other five trials provided supplements to children. PROCOMIDA 37 provided food to the entire family. Ostadrahimi 64 enrolled pregnant women from the 20 th week of gestational age and were provided daily fish oil supplements (120 mg docosahexaenoic acid and 180 mg eicosapentaenoic acid) or placebo up to 1 month into the postpartum, with their child being followed-up up to six months of age. At the 6-month assessment of this trial, there were no differences found in neither length (mean difference: 0.12, 95% CI: -0.52, 0.76) or head circumference (mean difference: -0.03, 95% CI: -0.38, 0.30) between the fish oil and placebo groups. Mofid 38 found that deworming interventions provided to mothers who tested positive for soiltransmitted helminth infection at baseline had a positive impact on mean length gain (Mean difference: 0.8; 95% CI: 0.1, 1.4) and LAZ (mean difference:0.5; 95% CI: 0.2, 0.8) of infants at six months of age.
Three of the five trials investigated the effectiveness of micronutrient supplements administered directly to children 47, 60, 63 . In Feliciano 47 , three different dosages of Vitamin D supplements (daily dose of 100, 200, and 400 IU) were provided to Chinese infants from birth up to six months of age; at the 6-months assessment, differences in length between the three groups were observed. Another placebo-controlled trial 63 conducted in Bangladesh found that daily zinc supplements (5 mg) to children between the age of one month to six months did not change the length or head circumference.
There were two trials that explored the role of food supplements to children. Simondon et al. 40 was a multi-national trial (Congo, Sengal, Bolivia, and New Caledonia) that randomized four-month old infants to either cereal-based precooked porridge fortified with MMN or the control group consisting of local food. The mean consumption of supplement varied from 133 to 189 kcal/day. There were no differences in length (cm) between the supplemented and control groups in all four countries at six months of age. In Lonnerdal et al. 60 , one-month old infants of non-breastfeeding mothers were randomized to receive regular formula or formula fortified with bovine osteopontin (65 or 130 mg/L). There were no differences in length or head circumference between children who were randomized to different formula groups. This trial also recruited infants whose mothers had expressed the desire to exclusively breastfeed up to six months of age and used this breastfeeding group as a non-randomized control. The breastfeeding group had a higher mean head circumference but similar length at six months of age.
Discussion
Despite recent global achievements towards improved MNCH, the existing evidence on exclusive breastfeeding period interventions for linear growth remains unclear. Our study aimed to improve the current evidence base by assessing the comparative effectiveness of interventions across several domains: micronutrients, food supplements, maternal education, WASH, deworming, and kangaroo care. Both network meta-analysis and pairwise meta-analysis techniques were undertaken to appraise and synthesize findings from relevant studies reporting the desired outcomes for infants of age 0-6 months in LMICs (i.e. LAZ and proportion of stunted), and due to limited number of studies, length and head circumference were summarized qualitatively.
We found that MMN supplementation to infants (i.e. MMN-C) was the only intervention that showed important improvement for linear growth during the exclusive breastfeeding period. However, this finding was limited to only one trial in the study 58 . Our analysis of kangaroo care also exhibited important improvements in growth in terms of increased head circumference and length growth velocity. However, kangaroo care interventions were excluded from the network meta-analysis and were analyzed separately via pairwise meta-analysis. This was due to the specific nature of this type of intervention, consisting of skin-to-skin contact between mothers' breasts during a precise period for a limited duration (of between 1 and 6 weeks). In relation to this point was the observed heterogeneity in the intervention duration between included studies, generally, creating an added challenge when making comparisons across interventions. Deworming and WASH interventions did not show any improvements in both LAZ and stunting.
The main strength of this study was the use of network meta-analysis to assess the effectiveness of different interventions from a large network of evidence compared to standardof-care 74 . Previous reviews have focused only on intervention(s) within a single domain (Table 1) . We used a broad evidence base that included multiple interventions from different domains to simultaneously analyze all potential treatment options and make full use of the available evidence within a single analysis 75, 76 . Additionally, appropriate statistical adjustments were made for clustering effects of cluster randomized clinical trials to enable the convergence of cluster and noncluster trials for our network meta-analysis. Nevertheless, the narrow parameters of our PICOS criteria may have limited the breadth of our evidence base. Ethical and resource challenges associated with conducting clinical trials with neonates may have influenced investigators' decision to undertake other non-randomized methodological approaches, such as observational studies. Additionally, since our population of interest focused on newborns living in LMICs, this prevented the inclusion of several trials conducted in non-LMICs. A number of studies assessed the effectiveness of long chain poly unsaturated fatty acids [77] [78] [79] ; an intervention that has demonstrated some promise for improving linear growth in neonates compared to standard of care. As these trials were limited to high income settings, we were unable to incorporate this data into our analyses.
In general, our analysis revealed that the existing evidence base for improving linear growth during the exclusive breastfeeding period is limited. Our scan and appraisal of the evidence resulted in a paucity of studies focused on this early life stage. The scarcity of evidence for this early life stage could be explained by several factors. Generally, clinical trials involving neonates are considerably more difficult to perform due to a range of ethical, physiological, pharmacometric, and economic challenges 80 . Obtaining ethical clearance for enrolling neonates can be extremely tasking, particularly with the need to preserve equipoise between intervention arms through balancing risk factors across intervention groups 80 . Such complexities can complicate both the study design and recruitment, especially as it pertains to trials conducted in resource scarce settings 81 . These reasons may explain to why the current evidence base for exclusive breastfeeding period is limited.
More clinical trial research is needed for the EBF period. To enhance the quality of evidence, it will beneficial if trials in the future will utilize more efficient trial designs, such as adaptive trial designs, that can better manage the range of uncertainties that may be associated with investigations focused on neonates 82,83 . It is important for mothers and infants living in resource limited settings that our assessment of interventions is thorough and appropriate for diverse contexts and settings. This will be a critical step to achieve the global goal of achieving a 40% reduction in the number of stunted children <5 years by 2025 84 .
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The authors state that exclusive breastfeeding during the first six months of life is critical for linear growth. Although the evidence is strong to support the benefits of exclusive breastfeeding on linear growth, the evidence for other interventions is not as clear. Numerous published reviews have assessed the effectiveness of micronutrients, food supplements, deworming, maternal education and kangaroo care during the exclusive breastfeeding period but their scope has been limited to single intervention within a single domain. Because the determinants of linear growth for the exclusive breastfeeding period is multi-faceted there is a need to summarize the evidence from multiple domains. The study therefore uses a comprehensive literature review for multiple intervention domains of micronutrients, food supplements, deworming, maternal education, water sanitation and hygiene and kangaroo care with a goal to summarize their effects on linear growth during the first 6 months of life (exclusive breastfeeding period). The main outcomes of interest were LAZ, stunting, changes in linear growth and changes in head circumference. Network meta-analysis was used to analyze data except kangaroo care which was analyzed using pairwise meta-analysis. The main finding from this analysis was that micronutrient supplementation to infants was the only intervention that showed improvement in linear growth during the exclusive breastfeeding period. This is a valuable study and generally well designed. It can be improved in the following minor areas:
Introduction:
The introduction could be tweaked to make it clearer. In the first paragraph it is not clear that linear growth is a clear benefit of exclusive breastfeeding during the first 6 months. For example "…is a critical life stage for early child development ." including linear growth
Method:
Clarify how the LAZ was calculated and if the same data was used to calculate LAZ among all trials.
There seems to be an error in reporting the length of the intervention among studies. For example on page 4/17 it reads "we excluded studies that did not report the effects of their respective interventions for at least three months". However in table 3 under outcomes it states "At least one
